Cargando…
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenge currently available coronavirus disease 2019 vaccines and monoclonal antibody therapies through epitope change on the receptor binding domain of the viral spike glycoprotein. Hence, there is a specific urgent need for...
Autores principales: | Yang, Kailu, Wang, Chuchu, Kreutzberger, Alex J. B., Ojha, Ravi, Kuivanen, Suvi, Couoh-Cardel, Sergio, Muratcioglu, Serena, Eisen, Timothy J., White, K. Ian, Held, Richard G., Subramanian, Subu, Marcus, Kendra, Pfuetzner, Richard A., Esquivies, Luis, Doyle, Catherine A., Kuriyan, John, Vapalahti, Olli, Balistreri, Giuseppe, Kirchhausen, Tom, Brunger, Axel T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546559/ https://www.ncbi.nlm.nih.gov/pubmed/36122200 http://dx.doi.org/10.1073/pnas.2210990119 |
Ejemplares similares
-
Drug discovery targeting SARS-CoV-2 membrane fusion
por: Yang, Kailu, et al.
Publicado: (2023) -
Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor
por: Yang, Kailu, et al.
Publicado: (2023) -
Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle
por: Yang, Kailu, et al.
Publicado: (2022) -
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
por: Kreutzberger, Alex J. B., et al.
Publicado: (2021) -
Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease
por: Kreutzberger, Alex J.B., et al.
Publicado: (2021)